X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Strides Arcolab with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

STRIDES SHASUN LTD vs DR. REDDYS LAB - Comparison Results

STRIDES SHASUN LTD    Change

Strides Arcolab is an Indian pharmaceutical company headquartered at Bangalore. The company is primarily involved in two businesses notably the pharma business and the specialized sterile products business branded as Agila. This segment focuses large... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    STRIDES SHASUN LTD DR. REDDYS LAB STRIDES SHASUN LTD/
DR. REDDYS LAB
 
P/E (TTM) x 7.4 32.7 22.5% View Chart
P/BV x 0.9 2.7 31.9% View Chart
Dividend Yield % 1.2 1.0 115.0%  

Financials

 STRIDES SHASUN LTD   DR. REDDYS LAB
EQUITY SHARE DATA
    STRIDES SHASUN LTD
Mar-17
DR. REDDYS LAB
Mar-17
STRIDES SHASUN LTD/
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,2753,397 37.5%   
Low Rs9182,560 35.9%   
Sales per share (Unadj.) Rs389.6856.5 45.5%  
Earnings per share (Unadj.) Rs28.078.0 35.9%  
Cash flow per share (Unadj.) Rs48.9139.9 35.0%  
Dividends per share (Unadj.) Rs4.5020.00 22.5%  
Dividend yield (eoy) %0.40.7 61.1%  
Book value per share (Unadj.) Rs303.1739.8 41.0%  
Shares outstanding (eoy) m89.42165.74 54.0%   
Bonus/Rights/Conversions ESOPBB-  
Price / Sales ratio x2.83.5 80.9%   
Avg P/E ratio x39.238.2 102.6%  
P/CF ratio (eoy) x22.421.3 105.3%  
Price / Book Value ratio x3.64.0 89.8%  
Dividend payout %16.125.7 62.7%   
Avg Mkt Cap Rs m98,036493,632 19.9%   
No. of employees `0005.822.7 25.6%   
Total wages/salary Rs m5,88131,068 18.9%   
Avg. sales/employee Rs Th6,005.96,259.0 96.0%   
Avg. wages/employee Rs Th1,014.01,369.8 74.0%   
Avg. net profit/employee Rs Th431.2569.7 75.7%   
INCOME DATA
Net Sales Rs m34,834141,961 24.5%  
Other income Rs m1,6861,715 98.3%   
Total revenues Rs m36,520143,676 25.4%   
Gross profit Rs m6,42824,722 26.0%  
Depreciation Rs m1,87210,266 18.2%   
Interest Rs m2,269634 357.9%   
Profit before tax Rs m3,97315,537 25.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m4349 1.0%   
Extraordinary Inc (Exp) Rs m-1,0060-   
Tax Rs m4702,965 15.9%   
Profit after tax Rs m2,50112,921 19.4%  
Gross profit margin %18.517.4 106.0%  
Effective tax rate %11.819.1 62.0%   
Net profit margin %7.29.1 78.9%  
BALANCE SHEET DATA
Current assets Rs m38,16596,837 39.4%   
Current liabilities Rs m30,40284,199 36.1%   
Net working cap to sales %22.38.9 250.3%  
Current ratio x1.31.2 109.2%  
Inventory Days Days7773 105.4%  
Debtors Days Days10498 107.0%  
Net fixed assets Rs m37,639102,552 36.7%   
Share capital Rs m894829 107.9%   
"Free" reserves Rs m26,210121,792 21.5%   
Net worth Rs m27,105122,621 22.1%   
Long term debt Rs m16,3775,449 300.6%   
Total assets Rs m81,168218,165 37.2%  
Interest coverage x2.825.5 10.8%   
Debt to equity ratio x0.60 1,359.7%  
Sales to assets ratio x0.40.7 66.0%   
Return on assets %5.96.2 94.6%  
Return on equity %9.210.5 87.6%  
Return on capital %12.112.9 93.4%  
Exports to sales %054.6 0.0%   
Imports to sales %09.4 0.0%   
Exports (fob) Rs mNA77,520 0.0%   
Imports (cif) Rs mNA13,274 0.0%   
Fx inflow Rs m13,46581,670 16.5%   
Fx outflow Rs m4,07626,355 15.5%   
Net fx Rs m9,38955,315 17.0%   
CASH FLOW
From Operations Rs m2,88121,444 13.4%  
From Investments Rs m-7,051-18,404 38.3%  
From Financial Activity Rs m3,382-3,692 -91.6%  
Net Cashflow Rs m-788-1,144 68.8%  

Share Holding

Indian Promoters % 27.7 25.5 108.6%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 37.8 5.4 700.0%  
FIIs % 8.6 35.3 24.4%  
ADR/GDR % 0.0 18.5 -  
Free float % 25.9 15.3 169.3%  
Shareholders   56,241 75,885 74.1%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare STRIDES SHASUN LTD With:   GLENMARK PHARMA  FULFORD INDIA  MERCK LTD  DIVIS LABORATORIES  UNICHEM LAB  

Compare STRIDES SHASUN LTD With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Tanks 300 Points; Capital Goods Stocks Down 3%(Closing)

After opening the day in red, share markets in India witnessed positive trading activity throughout the day and ended the day on a negative note.

Related Views on News

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

My Top Five Stocks After the Karnataka Elections(The 5 Minute Wrapup)

May 16, 2018

The markets seem confused. They're neither going up nor down. What should investors do? Consider Safe Stocks. Here's the top 5 Safe Stocks in the market today.

How A Storm Destroyed Rain Industries... And a Superb Small Cap Stock I Recommend(Profit Hunter)

May 17, 2018

A mutual fund regulation could cause small cap prices to tank - If you haven't been paying attention to your small caps - now is the time to catch the opportunities that start pouring in.

Has the Indian Home Buyer Become Smarter?(Vivek Kaul's Diary)

May 17, 2018

Home loans continue to grow, despite falling sales. What explains this phenomenon?

Looking Beyond the Colourful Prism of This Airline Company(Sector Info)

May 10, 2018

Can Interglobe Aviation Safely Fly Out of Turbulence?

HDFC Prudence Fund Now HDFC Balanced Advantage Fund - Time To Sell?(Outside View)

May 9, 2018

PersonalFN provides detail analysis on HDFC Balanced Advantage Fund (erstwhile HDFC Prudence Fund and HDFC Growth Fund).

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

STRIDES SHASUN LTD SHARE PRICE


May 18, 2018 (Close)

TRACK STRIDES SHASUN LTD

  • Track your investment in STRIDES SHASUN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON STRIDES SHASUN LTD

STRIDES SHASUN LTD 8-QTR ANALYSIS

COMPARE STRIDES SHASUN LTD WITH

MARKET STATS